Randomised Trial Comparing Three Different Schedules of Infusional 5FU and Raltitrexed Alone as First-Line Therapy in Metastatic Colorectal Cancer

Publisher： Karger

E-ISSN： 1423-0232|70|3|222-230

ISSN： 0030-2414

Source： Oncology, Vol.70, Iss.3, 2006-07, pp. : 222-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

First-Line Treatment with Irinotecan and Raltitrexed in Metastatic Colorectal Cancer

By  

Oncology, Vol. 68, Iss. 1, 2005-04 ,pp. : 58-63

Karger

Access to resources Recommend Favorite

A Randomized Phase II Trial of Pemetrexed plus Irinotecan (ALIRI) versus Leucovorin-Modulated 5-FU plus Irinotecan (FOLFIRI) in First-Line Treatment of Locally Advanced or Metastatic Colorectal Cancer

By  

Oncology, Vol. 73, Iss. 1-2, 2008-03 ,pp. : 9-20

Karger

Access to resources Recommend Favorite

Second-Line Chemotherapy with a Hybrid-Alternating Regimen of Bolus 5FU Modulated by Methotrexate and Infusional 5FU Modulated by Folinic Acid in Patients with Metastatic Colorectal Cancer Pretreated with 5FU

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 219-225

Karger

Access to resources Recommend Favorite

Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer

By  

Oncology, Vol. 77, Iss. 2, 2009-07 ,pp. : 113-119

Karger

Access to resources Recommend Favorite

A Randomised Phase II Study of Irinotecan in Combination with 5-FU/FA Compared with Irinotecan Alone as Second-Line Treatment of Patients with Metastatic Colorectal Carcinoma

By  

Oncology Research and Treatment, Vol. 30, Iss. 4, 2007-03 ,pp. : 169-174

Karger

Access to resources Recommend Favorite